LSTM Home > LSTM Research > LSTM Online Archive

Six-month therapy for abdominal tuberculosis

Jullien, Sophie, Jain, Siddharth, Ryan, Hannah and Ahuja, Vineet (2016) 'Six-month therapy for abdominal tuberculosis'. Cochrane Database of Systematic Reviews, Vol 16, CD012163.

Jullien_et_al-2016-.pdf - Published Version
Available under License Creative Commons Attribution.

Download (140kB) | Preview


This is a protocol for a Cochrane Review (Intervention). The objectives are as follows:

To compare the effects of six-month versus longer regimens for abdominal tuberculosis (TB), consisting of a two-month intensive phase with rifampicin, isoniazid, pyrazinamide, and ethambutol followed by a four-month or longer continuation phase including at least isoniazid and rifampicin.

Item Type: Article
Subjects: QV Pharmacology > Anti-Inflammatory Agents. Anti-Infective Agents. Antineoplastic Agents > QV 268 Antitubercular agents. Antitubercular antibiotics
QW Microbiology and Immunology > Bacteria > QW 125 Actinibacteria, Actinomycetales.
WF Respiratory System > Tuberculosis > WF 200 Tuberculosis (General)
WF Respiratory System > Tuberculosis > WF 310 Therapy
Faculty: Department: Clinical Sciences & International Health > Clinical Sciences Department
Digital Object Identifer (DOI):
SWORD Depositor: JISC Pubrouter
Depositing User: Stacy Murtagh
Date Deposited: 03 Jan 2018 13:44
Last Modified: 11 May 2018 08:51


View details

Actions (login required)

Edit Item Edit Item